#HealthCanada; #Moderna; #Covid19Vaccine; #NACI
Canada/Canadian-Media: The second COVID-19 vaccine, manufactured by Moderna gets authorized by Health Canada today for use for people 18 years of age or older, marking a critical step in ensuring the availability of additional COVID-19 vaccines to all Canadians in all parts of the country.
Moderna Covid-19 vaccine. Image credit: Facebook page
The different storage and handling requirements of the Moderna COVID-19 vaccine said Health Canada facilitates its distribution to isolated and remote communities, including the territories.
Moderna vaccine's compliance with the Health Department’s stringent safety, efficacy, and quality requirements was determined by Health Canada's thorough, independent review of Moderna’s submission on October 12, 2020.
The terms and conditions of the Moderna vaccine authorization require that vaccine manufacturer would keep Health Canada informed on safety, efficacy, and quality to ensure the benefits of the vaccine continue to be demonstrated through market use.
Health Canada is committed to openness and transparency to support vaccine's authorization, and said it is publishing a number of documents and added that more detailed information including a scientific summary and the full clinical trial data package will be made available in the coming weeks.
Once the vaccine starts to roll out on the market, Health Canada and the Public Health Agency of Canada will closely monitor the safety of the vaccine.
The safe use of the Moderna vaccine would be further supported by the National Advisory Committee on Immunization (NACI), which will update its recommendations on the use of COVID-19 vaccines to inform federal, provincial, and territorial immunization programs.